-11% Off

Buy Lucentis Vial from Canada

Original price was: $3,000.00.Current price is: $2,656.99.

Lucentis Vial 10mg/ml 0.23ml is a cutting-edge pharmaceutical marvel meticulously designed to address severe eye conditions with precision and efficacy. With its active ingredient, ranibizumab, Lucentis is a beacon of hope for individuals grappling with age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). This advanced medication targets and combats abnormal blood vessel growth and fluid leakage in the eye, offering new possibilities for patients facing these vision-threatening diseases.

Compare
Add to wishlist
Category:

Description

10 mg/mL 0.23 mL 1 Vial

Lucentis Vial 10mg/ml 0.23ml is a cutting-edge pharmaceutical marvel meticulously designed to address severe eye conditions with precision and efficacy. With its active ingredient, ranibizumab, Lucentis is a beacon of hope for individuals grappling with age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). This advanced medication targets and combats abnormal blood vessel growth and fluid leakage in the eye, offering new possibilities for patients facing these vision-threatening diseases.

Additional information

Usage:

Lucentis is administered through intravitreal injection by a qualified healthcare provider and plays a pivotal role in managing the following eye conditions:
1. Age-Related Macular Degeneration (AMD): Lucentis is a remarkable solution for wet AMD, a form of age-related macular degeneration characterized by the growth of abnormal blood vessels in the eye. By inhibiting vessel growth and reducing fluid leakage, Lucentis helps preserve and, in some cases, enhance vision.
2. Diabetic Macular Edema (DME): For individuals with diabetic macular edema, Lucentis offers a lifeline. It alleviates macular swelling, enhancing visual clarity and potentially preventing further vision deterioration.
3. Macular Edema Following Retinal Vein Occlusion (RVO): Lucentis is also a trusted treatment option for macular edema that occurs after a retinal vein occlusion, offering improved vision and an enhanced quality of life for patients.
Your eye specialist will determine the most suitable treatment plan for your specific condition, including the frequency and duration of Lucentis injections. Regular follow-up appointments are essential to monitor your progress and make any necessary adjustments to your treatment regimen
Side Effects:

As with any medication, Lucentis may come with side effects. It's crucial to be aware of these potential reactions while understanding that the benefits of treatment often outweigh the risks. Common side effects may include:
1. Eye Irritation: Some patients may experience mild eye irritation, such as redness or discomfort, following the injection. This typically subsides shortly after the procedure.
2. Increased Eye Pressure: Elevated eye pressure may occur in some patients but is usually manageable with appropriate measures.
3. Floaters: Temporary floaters, or the perception of specks or dark spots in your vision, may occur after treatment. This phenomenon is generally harmless and diminishes over time.
4. Eye Pain: Mild eye pain or discomfort at the injection site may be reported, but it is typically brief.
5. Increased Tearing: Excessive tearing or watering of the eyes may occur temporarily.
It's crucial to note that while serious side effects are rare, they can include severe eye infections and retinal detachment. If you experience persistent pain, vision changes, or any concerning symptoms following treatment, contact your eye specialist immediately.
Storage:

Proper storage of Lucentis Vial 10mg/ml 0.23ml is essential to maintain its effectiveness and safety. Store the vial at a temperature between 2°C to 8°C (36°F to 46°F) in its original packaging, protecting it from light. Prevent freezing or exposure to extreme temperatures. Make sure it stays out of the reach of children and pets. Only use Lucentis if it is within its expiration date.
Overdose:

In the rare event of an overdose or any unexpected reactions after receiving a Lucentis injection, seek immediate medical attention. An overdose may lead to severe eye complications or other adverse effects. To avoid the risk of overdose, always adhere to your healthcare professional's guidance regarding the appropriate dosage and administration schedule.

Related products